Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2023
In Vitro Activity of Eravacycline and Comparator Agents Against Bacterial Pathogens Isolated From Patients With Cancer, Kenneth Rolston, Bahgat Gerges, Lior Nesher, et al.
Spatial Regulation of the Glycocalyx Component Podocalyxin Is a Switch for Prometastatic Function, Alvaro Román-Fernández, Mohammed A Mansour, Fernanda G Kugeratski, et al.
Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma, Gabriele Romano, Francesca Paradiso, Peng Li, et al.
Superficial Low-Grade Fibromyxoid Sarcoma, Shira Ronen, Jennifer S Ko, Brian P Rubin, et al.
Image-Based Quantification of Histological Features as a Function of Spatial Location Using the Tissue Positioning System, Ruichen Rong, Yonglong Wei, Lin Li, et al.
Proteomic Predictors of Incident Diabetes: Results From the Atherosclerosis Risk in Communities (ARIC) Study, Mary R Rooney, Jingsha Chen, Justin B Echouffo-Tcheugui, et al.
Hypothyroidism following Radiotherapy for Head and Neck Cancer: A Systematic Review of the Literature and Opportunities to Improve the Therapeutic Ratio, Michael K Rooney, Lauren M Andring, Kelsey L Corrigan, et al.
Hypothyroidism Following Radiotherapy for Head and Neck Cancer: A Systematic Review of the Literature and Opportunities To Improve the Therapeutic Ratio, Michael K Rooney, Lauren M Andring, Kelsey L Corrigan, et al.
Patient-Reported Bowel Function and Bowel-Related Quality of Life After Pelvic Radiation for Rectal Adenocarcinoma: The Impact of Radiation Fractionation and Surgical Resection, Michael K Rooney, Brian De, Kelsey Corrigan, et al.
Patient-Reported Sexual Function, Bladder Function and Quality of Life for Patients with Low Rectal Cancers with or without a Permanent Ostomy, Michael K Rooney, Melisa Pasli, George J Chang, et al.
Tissue-Resident Memory T Cells Trigger Rapid Exudation and Local Antibody Accumulation, Pamela C Rosato, Sahar Lotfi-Emran, Vineet Joag, et al.
BCL2L11 Induction Mediates Sensitivity to Src and MEK1/2 Inhibition in Thyroid Cancer, Madison M Rose, Veronica L Espinoza, Katelyn J Hoff, et al.
Enolase Inhibitors as Early Lead Therapeutics against Trypanosoma brucei, Colm P Roster, Danielle LaVigne, Jillian E Milanes, et al.
Cytosolic DNA Sensing Protein Pathway Is Activated in Human Hearts With Dilated Cardiomyopathy, Leila Rouhi, Sirisha M Cheedipudi, Benjamin Cathcart, et al.
Daily Fosfomycin Versus Levofloxacin for Complicated Urinary Tract Infections, Nadine Rouphael, Patricia Winokur, Michael C Keefer, et al.
Dengue Outbreak Response During COVID-19 Pandemic, Key Largo, Florida, USA, 2020, Devin Rowe, Catherine McDermott, Ysla Veliz, et al.
Formate Supplementation Enhances Antitumor CD8+ T-cell Fitness and Efficacy of PD-1 Blockade, Jared H Rowe, Ilaria Elia, Osmaan Shahid, et al.
Ex vivo Drug Sensitivity Imaging-based Platform for Primary Acute Lymphoblastic Leukemia Cells, Lauren Rowland, Brandon Smart, Anthony Brown, et al.
Emerging Role of TAK1 in the Regulation of Skeletal Muscle Mass, Anirban Roy, Vihang A Narkar, and Ashok Kumar
Targeting Neddylation and Sumoylation in Chemoresistant Triple Negative Breast Cancer, Wei Ruan, Jiwen Li, Seungwon Choi, et al.
Next-Generation Ctla-4 Targeting Molecules and Combination Therapy: Promising Strategies for Improving Cancer Immunotherapy, Nils-Petter Rudqvist, Manushak Avagyan, and Dhan Chand
Immunotherapy Targeting Different Immune Compartments in Combination With Radiation Therapy Induces Regression of Resistant Tumors, Nils-Petter Rudqvist, Maud Charpentier, Claire Lhuillier, et al.
IRF1 Regulates Self-Renewal and Stress Responsiveness to Support Hematopoietic Stem Cell Maintenance, Alexandra J S Rundberg Nilsson, Hongxu Xian, Shabnam Shalapour, et al.
ADAR1 Deletion Causes Degeneration of the Exocrine Pancreas via Mavs-Dependent Interferon Signaling, Dhwani N Rupani, Fredrik I Thege, Vidhi Chandra, et al.
Surgical Results of the Lung Cancer Mutation Consortium 3 Trial: A Phase II Multicenter Single-Arm Study to Investigate the Efficacy and Safety of Atezolizumab As Neoadjuvant Therapy in Patients With Stages Ib-Select Iiib Resectable Non-small Cell Lung Cancer, Valerie W Rusch, Alan Nicholas, G Alexander Patterson, et al.